Literature DB >> 10832700

Inhibitory effects of tranilast on the proliferation and functions of human pterygium-derived fibroblasts.

M Isaji1, S Kikuchi, H Miyata, Y Ajisawa, K Araki-Inazawa, Y Tsukamoto, Y Amano.   

Abstract

PURPOSE: We studied the possibility that tranilast, an antiallergic and antiproliferative drug, may be beneficial for the treatment of pterygium.
METHODS: Pterygium-derived cells were identified by immunohistochemical methods. Growth rate of pterygium-derived cells was determined by using a hemocytometer. Chemotaxis was determined in a microchemotaxis chamber. Pterygium-derived cells were cultured on floating collagen gel, and the contracted diameter was measured. Collagen synthesis by pterygium-derived cells was determined by the collagenase digestive method. Tranilast was added to the culture medium at final concentrations of 0, 12.5, 25, 50, and 100 microg/ml.
RESULTS: Pterygium-derived cells were stained with anti-prolylhydroxylase and anti-alpha-smooth muscle actin, and identified as fibroblasts. Tranilast inhibited the proliferation and chemotaxis of pterygium-derived fibroblasts, and the collagen-gel contraction induced by these cells, but it exerted no inhibitory action on collagen synthesis by pterygium-derived fibroblasts.
CONCLUSION: Tranilast may be useful for suppressing the recurrence and, possibly, the development of pterygium.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10832700     DOI: 10.1097/00003226-200005000-00021

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  6 in total

1.  The expression of vascular endothelial growth factor in pterygium tissue of atopic patients.

Authors:  Hamid Gharaee; Mohammad Reza Shayegan; Mohammad Reza Khakzad; Sina Kianoush; A-Reza Varasteh; Mojtaba Sankian; Mojtaba Meshkat
Journal:  Int Ophthalmol       Date:  2014-10-26       Impact factor: 2.031

2.  Nanomicelle-generating Microneedles Loaded With Tranilast for Treatment of Hypertrophic Scars in a Rabbit Model.

Authors:  Pham Ngoc Chien; Jae Heon Jeong; Sun Young Nam; Su Yeon Lim; Nguyen VAN Long; Xin Rui Zhang; Ji Hoon Jeong; Chan Yeong Heo
Journal:  In Vivo       Date:  2022 Jul-Aug       Impact factor: 2.406

Review 3.  The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Authors:  Pedro Silva Cunha; Sérgio Laranjo; Jordi Heijman; Mário Martins Oliveira
Journal:  Front Cardiovasc Med       Date:  2022-07-04

Review 4.  Targeting the TGFβ signalling pathway in disease.

Authors:  Rosemary J Akhurst; Akiko Hata
Journal:  Nat Rev Drug Discov       Date:  2012-09-24       Impact factor: 84.694

5.  Cancer-associated fibroblast-targeted strategy enhances antitumor immune responses in dendritic cell-based vaccine.

Authors:  Yasuhiko Ohshio; Koji Teramoto; Jun Hanaoka; Noriaki Tezuka; Yasushi Itoh; Tohru Asai; Yataro Daigo; Kazumasa Ogasawara
Journal:  Cancer Sci       Date:  2015-01-16       Impact factor: 6.716

6.  Development of Sustained-Release Ophthalmic Formulation Based on Tranilast Solid Nanoparticles.

Authors:  Misa Minami; Ryotaro Seiriki; Hiroko Otake; Yosuke Nakazawa; Kazutaka Kanai; Tadatoshi Tanino; Noriaki Nagai
Journal:  Materials (Basel)       Date:  2020-04-03       Impact factor: 3.623

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.